Boric acid exert anti-cancer effect in poorly differentiated hepatocellular carcinoma cells via inhibition of AKT signaling pathway von Kahraman, Erkan, Göker, Erdem

Volltext

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial von Soria, Jean-Charles, Prof, Felip, Enriqueta, MD, Cobo, Manuel, MD, Lu, Shun, MD, Syrigos, Konstantinos, Prof, Lee, Ki Hyeong, MD, Göker, Erdem, MD, Georgoulias, Vassilis, Prof, Li, Wei, MD, Isla, Dolores, MD, Guclu, Salih Z, MD, Morabito, Alessandro, MD, Min, Young J, MD, Ardizzoni, Andrea, MD, Gadgeel, Shirish M, Prof, Wang, Bushi, PhD, Chand, Vikram K, MD, Goss, Glenwood D, Prof

Volltext

Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways von Kahraman, Erkan, Göker, Erdem

Volltext

Synthesis and characterization of folic acid-chitosan nanoparticles loaded with thymoquinone to target ovarian cancer cells von İnce, İskender, Yıldırım, Yeliz, Güler, Günnur, Medine, Emin İlker, Ballıca, Gülşah, Kuşdemir, Bekir Cem, Göker, Erdem

Volltext

Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations von Göker, Erdem, Altwairgi, Abdullah, Al-Omair, Ameen, Tfayli, Arafat, Black, Edward, Elsayed, Hany, Selek, Ugur, Koegelenberg, Coenraad

Volltext

Caffeic acid phenethyl ester (CAPE) Chitosan capped ZnO nanoparticles: Preparation, characterization, and its potential for the treatment of prostate cancer von İnce, İskender, Yıldırım, Yeliz, Göker, Erdem, Güler, Günnur, Saltan, Fehmi, Acar, Rıza, Gümüştaş, Barış, Medine, E. İlker

Volltext

Predictive role of neutropenia under crizotinib treatment in ALK-rearranged nonsmall cell lung cancer patients: A single-institution retrospective analysis von Gürsoy, Pınar, Çakar, Burcu, Nart, Deniz, Göker, Erdem

Volltext

EFFECTS OF NICKEL CHLORIDE ON CELL MORPHOLOGY AND MIGRATION IN NON-SMALL CELL LUNG CANCER CELL LINES von Kiris, Hakan Turan, Taskaya, Caglanur, Bahadir, Adil, Goker, Erdem

Volltext

PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival? von Güzel, Duygu, Terek, Coşan, Besler, Ayşegül, Serin, Gürdeniz, Önal, Züleyha, Akman, Levent, Göker, Erdem, Ali Şanli, Ulus, Zekioğlu, Osman, Özdemir, Necmettin, Özsaran, Aydın, Yildirim, Nuri

Volltext

Smoking Status in Relation to Clinicopathological Characteristics, Oncological Outcome, and Presence of Second Primary Lung Cancer in Patients with Bladder Cancer: A Population-bas... von Bolat, Deniz, Tinay, İlker, Aslan, Güven, Özkök, Serdar, Göker, Erdem, Akkoçlu, Atila

Volltext

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lu... von Gadgeel, Shirish, Goss, Glenwood, Soria, Jean-Charles, Felip, Enriqueta, Georgoulias, Vassilis, Lu, Shun, Cobo, Manuel, Syrigos, Konstantinos, Lee, Ki Hyeong, Göker, Erdem, Guclu, Salih Z, Isla, Dolores, Morabito, Alessandro, Dupuis, Nicholas, Bühnemann, Claudia, Krämer, Nicole, Solca, Flavio, Ehrnrooth, Eva, Ardizzoni, Andrea

Volltext

Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience von Gursoy, Pinar, Cakar, Burcu, On, Sercan, Goker, Erdem, Nart, Deniz

Volltext

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial von Goss, Glenwood D., Cobo, Manuel, Lu, Shun, Syrigos, Konstantinos, Lee, Ki Hyeong, Göker, Erdem, Georgoulias, Vassilis, Isla, Dolores, Morabito, Alessandro, Min, Young J., Ardizzoni, Andrea, Bender, Shaun, Cseh, Agnieszka, Felip, Enriqueta

Volltext

Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group von Kaplan, Muhammet Ali, Şendur, Mehmet Ali Nahit, Cangır, Ayten Kayı, Fırat, Pınar, Göker, Erdem, Kılıçkap, Saadettin, Oyan, Başak, Büge Öz, Ayşim, Özdemir, Feyyaz, Özyiğit, Gökhan

Volltext

597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer von Deme, Dániel, Öven, Bala, Göker, Erdem, Lang, Istvan, Brück, Patrick, Wenger, Michael, Munshi, Neru, Schell, Thomas, Ünsal-Kaçmaz, Kezi, Markman, Janet, Rietschel, Petra, Yang, Huyuan, Tuereci, Oezlem, Sahin, Ugur, Atmaca, Akin, Forde, Patrick

Volltext

Nickel chloride induces anticancer biological responses in hepatocellular carcinoma cell lines von Kahraman, Erkan, Goker, Erdem

Volltext

LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following F... von Hirsh, Vera, MD, Gadgeel, Shirish, MD, Soria, Jean-Charles, MD, Felip, Enriqueta, MD, Cobo, Manuel, MD, Lu, Shun, MD, Syrigos, Konstantinos, PhD, Lee, Ki Hyeong, MD, Göker, Erdem, MD, Georgoulias, Vassilis, MD, Li, Wei, MD, Isla, Dolores, MD, Guclu, Salih Zeki, MD, Morabito, Alessandro, MD, Min, Young Joo, MD, Ardizzoni, Andrea, MD, Cromer, Jamie, MMSc, Wang, Bushi, PhD, Chand, Vikram, MD, Goss, Glenwood, MD

Volltext

Leptomeningeal carcinomatosis of gastric adenocarcinoma von BULUT, Gulcan, ERDEN, Asuman, KARACA, Burcak, GOKER, Erdem

Volltext

Algorithms for scheduling of chemotherapy plans von Sevinc, Suleyman, Sanli, Ulus Ali, Goker, Erdem

Volltext

Controlled Release of Methotrexate from W/O Microemulsion and Its In Vitro Antitumor Activity von Karasulu, H. Ye im, Karabulut, Bülent, Göker, Erdem, Güneri, Tamer, Gabor, Franz

Volltext